IMC-Chicago, LLC
- SEC CIK
- 0001452861
- Latest filing
- Aug 6, 2026
CRSP holding history
CRISPR Therapeutics AG in every 13F filed by IMC-Chicago, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CRSP overviewAll 13F holders of CRSPFull Q2 2026 holdings
- Shares (Q2 2026)
- 10,709
- Value
- $584.1K
- % of portfolio
- <0.1%
- Quarters held
- 15
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 10,709 | $584.1K | <0.1% | +10,709 | New | Holders |
| Q3 2025 | 0 | $0 | 0.0% | −23,080−100.0% | Sold out | Holders |
| Q2 2025 | 23,080 | $1.12M | <0.1% | −39,134−62.9% | Reduced | Holders |
| Q1 2025 | 62,214 | $2.12M | 0.1% | −24,255−28.1% | Reduced | Holders |
| Q4 2024 | 86,469 | $3.40M | 0.1% | +86,469 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −36,722−100.0% | Sold out | Holders |
| Q1 2024 | 36,722 | $2.50M | 0.1% | −1,495−3.9% | Reduced | Holders |
| Q4 2023 | 38,217 | $2.39M | 0.1% | +6,914+22.1% | Added | Holders |
| Q3 2023 | 31,303 | $1.42M | 0.1% | +15,640+99.9% | Added | Holders |
| Q2 2023 | 15,663 | $879.3K | <0.1% | +1,731+12.4% | Added | Holders |
| Q1 2023 | 13,932 | $630.1K | 0.1% | −6,974−33.4% | Reduced | Holders |
| Q4 2022 | 20,906 | $849.8K | 0.2% | +20,906 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −21,994−100.0% | Sold out | Holders |
| Q1 2022 | 21,994 | $1.38M | 0.1% | −24,086−52.3% | Reduced | Holders |
| Q4 2021 | 46,080 | $3.49M | 0.1% | +18,036+64.3% | Added | Holders |
| Q3 2021 | 28,044 | $3.14M | 0.3% | +15,291+119.9% | Added | Holders |
| Q2 2021 | 12,753 | $2.06M | 0.2% | −7,667−37.5% | Reduced | Holders |
| Q1 2021 | 20,420 | $2.49M | 0.2% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.